GlassScriptPhysician profile
Cullen Dean Ryburn
NPI 1679950976
$3,192.75
in general payments reported to CMS, 2019-2025
16 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $331 · 2021: $210 · 2022: $235 · 2023: $889 · 2024: $464 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385 · Travel and Lodging: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.40 |
| Travel and Lodging | $303.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,574.32 | 2019-2025 | Clareon, Centurion, Argos |
| Rxsight INC | $394.48 | 2021-2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| New World Medical,INC. | $235.96 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $200.24 | 2019-2025 | Healon Duet Pro, Tecnis Iol, Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $184.31 | 2019-2021 | |
| Genentech USA, INC. | $141.63 | 2019 | |
| Allergan, INC. | $122.96 | 2019 | |
| Dompe US, INC. | $94.89 | 2021-2025 | Oxervate |
| Glaukos Corporation | $71.71 | 2020-2025 | Photrexa Viscous and Photrexa |
| Abbvie INC. | $38.15 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $37.11 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $30.90 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $18.04 | 2023 | Acthar |
| Bausch & Lomb Americas INC. | $17.38 | 2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $15.64 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $15.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cullen Ryburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.